-+ 0.00%
-+ 0.00%
-+ 0.00%

Nexgel appoints Sequence LifeScience executives Brian Kieser, Kevin Harris to board

PUBT·05/06/2026 13:01:09
Listen to the news
Nexgel appoints Sequence LifeScience executives Brian Kieser, Kevin Harris to board
  • Nexgel appointed Brian J. Kieser and Kevin Harris to Board of Directors.
  • Kieser serves as CEO of Sequence LifeScience; Harris serves as COO of Sequence LifeScience.
  • Sequence LifeScience recently led financing tied to closing acquisition of Celularity’s degenerative disease segment, including a USD 5.5 million strategic investment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexgel Inc. published the original content used to generate this news brief on May 06, 2026, and is solely responsible for the information contained therein.